Bruce L Wilkoff

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients
    Bruce L Wilkoff
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 15:1002-9. 2004
  2. ncbi Lead-induced venous thrombosis:consequences?
    Bruce L Wilkoff
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 15:1263-4. 2004
  3. ncbi Improved extraction of ePTFE and medical adhesive modified defibrillation leads from the coronary sinus and great cardiac vein
    Bruce L Wilkoff
    Cleveland Clinic Foundation, Department of Cardiology, Cleveland, OH 44195, USA
    Pacing Clin Electrophysiol 28:205-11. 2005
  4. ncbi ICDs: dealing with less than perfect
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 16:796-7. 2005
  5. ncbi Electrical conduction disturbance effects on dynamic changes of functional mitral regurgitation
    Shota Fukuda
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 46:2270-6. 2005
  6. ncbi Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, 9500 Euclid Ave, Desk F 15, Cleveland, OH 44195, USA
    JAMA 288:3115-23. 2002
  7. ncbi The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Card Electrophysiol Rev 7:468-72. 2003
  8. ncbi Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment
    Bruce L Wilkoff
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Heart Rhythm 8:65-73. 2011
  9. ncbi Electrical therapy for heart failure: evolving indications and choices
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Tex Heart Inst J 32:212-4. 2005
  10. ncbi Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Director of Cardiac Pacing and Tachyarrhythmia Devices, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F 15, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 52:541-50. 2008

Detail Information

Publications93

  1. ncbi Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients
    Bruce L Wilkoff
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 15:1002-9. 2004
    ....
  2. ncbi Lead-induced venous thrombosis:consequences?
    Bruce L Wilkoff
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 15:1263-4. 2004
  3. ncbi Improved extraction of ePTFE and medical adhesive modified defibrillation leads from the coronary sinus and great cardiac vein
    Bruce L Wilkoff
    Cleveland Clinic Foundation, Department of Cardiology, Cleveland, OH 44195, USA
    Pacing Clin Electrophysiol 28:205-11. 2005
    ..These shocking coils, as documented by pathologic examination of animal investigations, often become tightly encapsulated by fibrosis and can be very difficult to remove...
  4. ncbi ICDs: dealing with less than perfect
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 16:796-7. 2005
  5. ncbi Electrical conduction disturbance effects on dynamic changes of functional mitral regurgitation
    Shota Fukuda
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 46:2270-6. 2005
    ..The CRT decreased regurgitation flow volume by reducing early-systolic MR but not late-systolic MR, resulting in the change in phasic pattern of functional MR...
  6. ncbi Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, 9500 Euclid Ave, Desk F 15, Cleveland, OH 44195, USA
    JAMA 288:3115-23. 2002
    ..Most currently implanted ICD devices provide dual-chamber pacing therapy. The most common comorbid cause for mortality in this population is congestive heart failure...
  7. ncbi The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Card Electrophysiol Rev 7:468-72. 2003
    ....
  8. ncbi Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment
    Bruce L Wilkoff
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Heart Rhythm 8:65-73. 2011
    ..Magnetic resonance imaging (MRI) of pacemaker patients is contraindicated due to documented potential risks to the patient from hazardous interactions between the MRI and pacemaker system...
  9. ncbi Electrical therapy for heart failure: evolving indications and choices
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Tex Heart Inst J 32:212-4. 2005
  10. ncbi Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Director of Cardiac Pacing and Tachyarrhythmia Devices, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F 15, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 52:541-50. 2008
    ....
  11. ncbi How to treat and identify device infections
    Bruce L Wilkoff
    Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio 44195, USA
    Heart Rhythm 4:1467-70. 2007
  12. ncbi A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial
    Bruce L Wilkoff
    The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 48:330-9. 2006
    ....
  13. ncbi HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations
    Bruce L Wilkoff
    Cleveland Clinic, Cleveland, Ohio, USA
    Heart Rhythm 5:907-25. 2008
  14. ncbi The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy
    John Rickard
    Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Pacing Clin Electrophysiol 34:604-11. 2011
    ..The relationship between QRS narrowing and response to cardiac resynchronization therapy (CRT) has been controversial...
  15. ncbi Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy
    David Verhaert
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Circ Cardiovasc Imaging 5:21-6. 2012
    ..We sought to evaluate the relationship between serial measurements of functional MR and reverse remodeling and outcomes in patients undergoing CRT...
  16. ncbi The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial
    Bruce L Wilkoff
    Cleveland Clinic, Cleveland, Ohio, USA
    J Am Coll Cardiol 53:872-80. 2009
    ..The purpose of this study was to determine whether atrial pacing is a safe alternative to minimal (backup-only) ventricular pacing in defibrillator recipients with impaired ventricular function...
  17. ncbi QRS fragmentation is not associated with poor response to cardiac resynchronization therapy
    John Rickard
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Ann Noninvasive Electrocardiol 16:165-71. 2011
    ..Whether fQRS is associated with progressive left ventricular remodeling and increased mortality in patients receiving cardiac resynchronization therapy (CRT) is unclear...
  18. ncbi Cardiac resynchronization therapy in non-left bundle branch block morphologies
    John Rickard
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Pacing Clin Electrophysiol 33:590-5. 2010
    ..Little is known about the response to CRT in patients with right bundle branch block (RBBB) or non-specific intraventricular conduction delay (IVCD) compared with traditionally studied patients with left bundle branch block (LBBB)...
  19. ncbi Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure
    J David Burkhardt
    Department of Cardiovascular Medicine and Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Desk F15, Cleveland, OH 44195, USA
    Circulation 115:2208-20. 2007
    ..Finally, there are ongoing controversies and many as yet unanswered questions that are the subject of ongoing and planned clinical trials...
  20. ncbi Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology
    John Rickard
    Heart and Vascular Institute Cleveland Clinic, Ohio, USA
    Am J Cardiol 108:1576-80. 2011
    ..66 to 0.94, p = 0.005). In patients with advanced heart failure and non-LBBB morphologies, a wider baseline QRS duration is an important determinant of enhanced reverse ventricular remodeling and improved long-term outcomes after CRT...
  21. ncbi Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure
    Wilfried Mullens
    Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Am Coll Cardiol 53:600-7. 2009
    ..Our aim was to determine the potential hemodynamic contributions of cardiac resynchronization therapy (CRT) in patients admitted for advanced decompensated heart failure...
  22. ncbi Elevated red cell distribution width is associated with impaired reverse ventricular remodeling and increased mortality in patients undergoing cardiac resynchronization therapy
    John Rickard
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Congest Heart Fail 18:79-84. 2012
    ..83; 95% confidence interval, 0.69-0.99; P=.047). The presence of elevated RDW is associated with less reverse left ventricular remodeling in patients with advanced heart failure undergoing CRT...
  23. ncbi Initial experience with the Evolution mechanical dilator sheath for lead extraction: safety and efficacy
    Ayman A Hussein
    Cleveland Clinic, Cleveland, Ohio, USA
    Heart Rhythm 7:870-3. 2010
    ..The Evolution mechanical dilator sheath is a new lead extraction tool that uses a rotational mechanism and a bladed tip to overcome fibrosis...
  24. ncbi Characterization of super-response to cardiac resynchronization therapy
    John Rickard
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Heart Rhythm 7:885-9. 2010
    ..A minority of patients experience a dramatic response to CRT (super-responders), but the attributes associated with these patients have not been fully characterized...
  25. ncbi Cardiac implantable electronic device infections: presentation, management, and patient outcomes
    Khaldoun G Tarakji
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1043-7. 2010
    ..Indications for cardiac implantable electronic devices (CIEDs) are increasing. Although CIED infections occur infrequently, the impact of this outcome is expected to be substantial...
  26. ncbi Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration
    Matthias Dupont
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 60:592-8. 2012
    ..The goal of this study was to examine the relative impact of QRS morphology and duration in echocardiographic responses to cardiac resynchronization therapy (CRT) and clinical outcomes...
  27. ncbi Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up
    David Verhaert
    Department of Cardiovascular Medicine, Section of Cardiac Imaging, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Am Coll Cardiol 55:1788-95. 2010
    ..The purpose of this study was to describe the long-term course of left ventricular remodeling induced by cardiac resynchronization therapy (CRT), adjusting for the confounding effect of patient loss due to disease...
  28. ncbi The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy
    Luigi Di Biase
    Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH, USA
    Eur Heart J 29:2497-505. 2008
    ..We assessed the relationship between cardiac resynchronization therapy (CRT)-induced reverse remodelling and mortality during a long-term follow-up in a prospective observational study...
  29. ncbi Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy
    Ross T Murphy
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 97:1615-21. 2006
    ..In conclusion, pacing at the site of maximal mechanical delay was associated with reverse remodeling. Individually tailored LV lead positioning should be considered before CRT...
  30. ncbi Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database
    Daniel J Cantillon
    Cardiovascular Medicine Electrophysiology, Cleveland Clinic, Heart and Vascular Institute, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1567-71. 2010
    ..Pacemaker-requiring bradyarrhythmias after cardiac transplantation are common, and rarely can lead to sudden cardiac death. Prior outcomes studies have been limited to single-center data...
  31. ncbi Effectiveness of implantable cardioverter-defibrillator lead coil treatments in facilitating ease of extraction
    Joseph W Hackler
    Department of Internal Medicine, Medicine Institute, Cleveland, Ohio, USA
    Heart Rhythm 7:890-7. 2010
    ..Expanded polytetrafluoroethylene (ePTFE) coated and medical adhesive back-filled (MABF) implantable cardioverter-defibrillator (ICD) coils have been promoted to reduce the fibrous ingrowth into coils that can complicate lead extraction...
  32. ncbi The impact of left ventricular size on response to cardiac resynchronization therapy
    John Rickard
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH, USA
    Am Heart J 162:646-53. 2011
    ..We examined changes in left ventricular ejection fraction (LVEF) and survival in patients with NDCM or SDCM compared with those with traditionally studied moderately dilated cardiomyopathy...
  33. ncbi Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy
    Mark A Iler
    Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiol 101:359-63. 2008
    ..In patients with increased QRS durations despite CRT, closer follow-up or reassessment for alternative management strategies may be warranted...
  34. ncbi The role of swab and tissue culture in the diagnosis of implantable cardiac device infection
    Jimmy Dy Chua
    Department of Pathology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Pacing Clin Electrophysiol 28:1276-81. 2005
    ..Positive cultures by pocket swab or tissue cultures in the absence of clinical signs and symptoms of infection does not imply infection or the need for specific therapy...
  35. ncbi Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program
    Wilfried Mullens
    Department of Cardiovascular Medicine, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 53:765-73. 2009
    ..Our aim was to determine the feasibility and value of a protocol-driven approach to patients with cardiac resynchronization therapy (CRT) who did not exhibit a positive response long after implant...
  36. ncbi Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator
    Daniel J Cantillon
    Cleveland Clinic, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:466-71. 2010
    ..It is unknown whether implantable cardioverter-defibrillator (ICD) detection and therapy can extend survival in the VAD population...
  37. ncbi Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy
    John Rickard
    Department of Cardiovascular Disease, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiol 105:522-6. 2010
    ..These changes were similar to patients in the NIC cohort. In conclusion, patients with AIC may derive a significant echocardiographic and symptomatic benefit from CRT, which is similar to that seen in other forms of NIC...
  38. ncbi Strategic choices to reduce implantable cardioverter-defibrillator-related morbidity
    Oussama Wazni
    Department of Cardiovascular Medicine, Cleveland Clinic, Main Campus, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Nat Rev Cardiol 7:376-83. 2010
    ....
  39. ncbi QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias
    Vidyasagar Kalahasti
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 92:798-803. 2003
    ..Whether QRS duration represents only a marker for mortality or if modification of this factor using resynchronization therapies will impact mortality merits further study...
  40. ncbi Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support
    Daniel J Cantillon
    Cleveland Clinic, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland, OH 44195, USA
    Heart Rhythm 9:859-64. 2012
    ..Ventricular tachyarrhythmias (VT) are common among ventricular assist device (VAD) recipients, yet electrophysiologic (EP) characteristics and catheter ablation outcomes remain uncharacterized...
  41. ncbi Chest radiography is a poor predictor of left ventricular lead position in patients undergoing cardiac resynchronization therapy: comparison with multidetector computed tomography
    John Rickard
    Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Heart and Vascular Institute, J1 5, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Interv Card Electrophysiol 32:59-65. 2011
    ..While the post-implant posterior-anterior (PA) and lateral chest X-ray (CXR) is commonly used to determine the position of the LV lead, the accuracy to which the CXR can correctly localize the LV lead is unknown...
  42. ncbi Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy
    Navin Kedia
    Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 98:780-5. 2006
    ..AV delay optimization based on Doppler echocardiographic determination of optimal diastolic filling is useful and safe in patients who undergo CRT...
  43. ncbi Pacing in heart failure: the benefit of resynchronization
    Yaariv Khaykin
    Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, The Cleveland Clinic, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 70:841, 845-6, 848-50, passim. 2003
    ..It may help patients with systolic heart failure and conduction disturbances by optimizing myocardial performance...
  44. ncbi Nonthoracotomy implantable defibrillator lead extraction: results and comparison with extraction of pacemaker leads
    Eduardo B Saad
    Section of Cardiac Pacing and Electrophysiology, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Pacing Clin Electrophysiol 26:1944-50. 2003
    ..In experienced hands, excellent success rates should be achieved with a low incidence of complications...
  45. ncbi Long-term outcomes and clinical predictors for pacing after cardiac transplantation
    Daniel J Cantillon
    Department of Cardiovascular Medicine, Cleveland Clinic, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland, OH 44195, USA
    J Heart Lung Transplant 28:791-8. 2009
    ..This study evaluated the predictors for PPM requirement, long-term outcomes, and influence of implant timing and device programming on prognosis after cardiac transplant...
  46. ncbi Cardiac venous left ventricular lead removal and reimplantation following device infection: a large single-center experience
    John Rickard
    Heart and Vascular Institute Cleveland Clinic, Cleveland, Ohio, USA
    J Cardiovasc Electrophysiol 23:1213-6. 2012
    ..Reimplantation of CV leads is achievable in roughly 83% of patients, a figure lower than nationally quoted estimates for de novo implantations. (J Cardiovasc Electrophysiol, Vol. 23, pp. 1213-1216, November 2012)...
  47. ncbi Remote monitoring of cardiovascular devices: a time and activity analysis
    Edmond M Cronin
    Section of Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio Electronic address
    Heart Rhythm 9:1947-51. 2012
    ..Remote monitoring (RM) may be less time-consuming compared to in-office follow-up; however, its effect on the device clinic workflow has not been clarified...
  48. ncbi Giant flow reversal in pulmonary venous flow as a possible mechanism for asynchronous pacing-induced heart failure
    Tomotsugu Tabata
    Section of Cardiovascular Imaging, Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Am Soc Echocardiogr 18:722-8. 2005
    ..We evaluated the impact of asynchronous rapid ventricular pacing on LA hemodynamics in this model...
  49. ncbi QRS prolongation induced by cardiac resynchronization therapy correlates with deterioration in left ventricular function
    John Rickard
    Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Blvd, Cleveland, OH 44122, USA
    Heart Rhythm 9:1674-8. 2012
    ..A subset of "nonresponders" experience deterioration in LV function following cardiac resynchronization therapy (CRT). Characteristics of this patient population, however, have not been studied...
  50. ncbi The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy
    Lucie Riedlbauchova
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    J Cardiovasc Electrophysiol 20:50-7. 2009
    ..Around 30% of patients do not respond to cardiac resynchronization therapy (CRT). Nonischemic cardiomyopathy has been identified as an independent predictor of response to CRT, probably due to the absence of compact scar...
  51. ncbi Complications of pacemakers and defibrillators in the elderly
    Shane M Bailey
    The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA
    Am J Geriatr Cardiol 15:102-7. 2006
    ..Recent work suggests that older age, by itself, is not associated with a significant increase in the complication rates from these devices and should not preclude their use...
  52. ncbi Delayed lead perforation: a disturbing trend
    Mohammed N Khan
    Cleveland Clinic Foundation, Department of Cardiology, Cleveland, OH 44195, USA
    Pacing Clin Electrophysiol 28:251-3. 2005
    ..All patients tolerated extraction without complication. CONCLUSION: Based on these cases, we recommend a management scheme for patients who present with delayed lead perforation...
  53. ncbi Malfunctions in implantable cardiac devices: putting the risk in perspective
    J David Burkhardt
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 72:736, 738, 742 passim. 2005
  54. ncbi Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation
    Bruce S Stambler
    University Hospitals of Cleveland, Case Western Reserve University, 22200 Euclid Avenue, Cleveland, Ohio 44106, USA
    J Cardiovasc Electrophysiol 14:1180-6. 2003
    ..Whether the right ventricular outflow tract (RVOT) is a more optimal site for permanent pacing in patients with congestive heart failure (CHF) has not been established...
  55. ncbi Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity
    Jay Sengupta
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue J2 2, Cleveland, OH 44195, USA
    Heart Rhythm 9:1619-26. 2012
    ..Although estimated risks of ICD generators under advisory are low, dependency on ICD therapies to prevent sudden death justifies the assessment of long-term mortality...
  56. ncbi Percutaneous extraction of stented device leads
    Bryan Baranowski
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA
    Heart Rhythm 9:723-7. 2012
    ..There are limited published data regarding the percutaneous extraction of device leads jailed by a venous stent...
  57. ncbi Minimally invasive left ventricular epicardial lead placement: surgical techniques for heart failure resynchronization therapy
    Jose L Navia
    Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Ann Thorac Surg 79:1536-44; discussion 1536-44. 2005
    ..This study aims to determine perioperative and early postoperative outcome of minimally invasive left ventricular lead placement as a management strategy for heart failure, comparing minithoracotomy and endoscopic approaches...
  58. ncbi Current status and future expectations for multisite pacing in heart failure
    Eduardo B Saad
    Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F15, Cleveland, OH 44122, USA
    Curr Cardiol Rep 4:238-47. 2002
    ..This article reviews the rationale, delivery modes, and available data supporting multisite cardiac pacing as an alternative form of therapy for the failing heart...
  59. ncbi Frequency and associations of symptomatic deterioration after dual-chamber defibrillator implantation in patients with ischemic or idiopathic dilated cardiomyopathy
    Eduardo B Saad
    Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, Cleveland Clinic Foundation, Cleveland, Ohio 44122, USA
    Am J Cardiol 90:79-82. 2002
  60. ncbi Pacemaker and ICD leads: strategies for long-term management
    P Peter Borek
    Department of Cardiology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F15, Cleveland, OH 44195 5014, USA
    J Interv Card Electrophysiol 23:59-72. 2008
    ..The latter is very safe and effective when performed in experienced centers. Finally, lead follow-up must be routinely conducted to identify problematic leads, prevent further reimplantations, and guide future research...
  61. ncbi Fibrotic tissue growth into the extendable lobes of an active fixation coronary sinus lead can complicate extraction
    Bryan Baranowski
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Pacing Clin Electrophysiol 34:e64-5. 2011
    ..Significant, prolonged manual traction was required to free the lead from the cardiac vein. Inspection demonstrated fibrotic tissue growth into the lead lobes. Such growth may lead to an increase in extraction complications and failures...
  62. ncbi HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and
    Bruce L Wilkoff
    Cleveland Clinic, Cleveland, Ohio, USA
    Europace 10:707-25. 2008
  63. ncbi Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions
    Oussama Wazni
    Department of Cardiovascular Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 55:579-86. 2010
    ..This study sought to examine the safety and efficacy of laser-assisted lead extraction and the indications, outcomes, and risk factors in a large series of consecutive patients...
  64. ncbi Intravascular pacemaker and defibrillator lead extraction: a state-of-the-art review
    Atul Verma
    Cleveland Clinic Foundation, Section of Cardiac Electrophysiology and Pacing, Ohio 44195, USA
    Heart Rhythm 1:739-45. 2004
  65. ncbi Transiliac ICD implantation: defibrillation vector flexibility produces consistent success
    Chi Keong Ching
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 6:978-83. 2009
    ....
  66. ncbi North American Society of Pacing and Electrophysiology. Standards of professional practice for the allied professional in pacing and electrophysiology
    Melanie T Gura
    Heart Group, Incorporated, Akron, Ohio, USA
    Pacing Clin Electrophysiol 26:127-31. 2003
  67. ncbi Remote interrogation and monitoring of implantable cardioverter defibrillators
    George K Joseph
    Cleveland Clinic Foundation, Division of Electrophysiology and Pacing, Cleveland, OH 44195, USA
    J Interv Card Electrophysiol 11:161-6. 2004
    ..Although transtelephonic monitoring is routine for pacemaker follow-up there is no systematically collected data supporting remote interrogation and monitoring (RIM) of ICD patients...
  68. ncbi The strength-duration relationship of monophasic waveforms with varying capacitance sizes in external defibrillation
    Yoshio Yamanouchi
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Pacing Clin Electrophysiol 26:2213-8. 2003
    ..The E50 is more sensitive to tilt values changes in larger capacitance waveforms. This study suggests that the optimal combination between capacitance and tilt may be 120 microF and 55%-75% for external defibrillation...
  69. ncbi Hypersensitivity reactions associated with endovascular devices
    Golara Honari
    Department of Dermatology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Contact Dermatitis 59:7-22. 2008
    ..Reports of putative hypersensitivity reactions to endovascular devices, including coronary stents, perforated foramen occluders, pacemakers and implantable cardioverter defibrillators are also reviewed...
  70. ncbi Noninvasive assessment of cardiac resynchronization therapy for congestive heart failure using myocardial strain and left ventricular peak power as parameters of myocardial synchrony and function
    Zoran B Popovic
    Cardiovascular Imaging Center, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Cardiovasc Electrophysiol 13:1203-8. 2002
    ..The aim of this study was to assess the acute effects of cardiac resynchronization therapy by noninvasive techniques...
  71. ncbi Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases
    Karen B James
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Kaufman Center for Heart Failure, Cleveland, Ohio 44195, USA
    Tex Heart Inst J 33:19-22. 2006
    ..Although the patients in this survey were a very high-risk group, a small subset was weaned and had stable short-term survival...
  72. ncbi Percutaneous treatment for pacemaker-associated superior vena cava syndrome
    Albert W Chan
    Section of Interventional Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Pacing Clin Electrophysiol 25:1628-33. 2002
    ....
  73. ncbi Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
    Merritt H Raitt
    Portland VA Medical Center, Oregon Health and Science University, Portland, Oregon, USA
    Am J Cardiol 91:812-6. 2003
    ..These findings suggest there are important differences in the electrophysiologic characteristics of these 2 patient populations...
  74. ncbi Clinical study of the laser sheath for lead extraction: the total experience in the United States
    Charles L Byrd
    Broward General Medical Center, Fort Lauderdale, Florida, USA
    Pacing Clin Electrophysiol 25:804-8. 2002
    ..Success is independent of laser sheath size. Major complications can be expected in < 2% of patients, and occur more often during an investigator's early experience...
  75. ncbi Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and
    Mark D Carlson
    University Hospitals of Cleveland and Case Western Reserve University, OH, USA
    Heart Rhythm 3:1250-73. 2006
  76. ncbi Experience with a dual chamber implantable defibrillator
    Volker Kühlkamp
    Department of Cardiology, Universitatsklinikum Tubingen, Germany
    Pacing Clin Electrophysiol 25:1041-8. 2002
    ..The dual chamber detection algorithm appropriately recognized supraventricular tachycardia with rapid ventricular rates 72% of the time while maintaining 100% detection of sustained ventricular tachyarrhythmias...
  77. ncbi Health values before and after pacemaker implantation
    Francisco Lopez-Jimenez
    Division of Cardiology, Mount Sinai Medical Center, and Cardiovascular Associates of Miami, Miami Beach, Fla 33140, USA
    Am Heart J 144:687-92. 2002
    ..The values reported here may be used as a means of calculating the cost-effectiveness of different pacing modalities...
  78. ncbi Pacemaker and ICD malfunction--an incomplete picture
    Bruce L Wilkoff
    JAMA 295:1944-6. 2006
  79. ncbi Rate responsive pacing using transthoracic impedance minute ventilation sensors: a multicenter study on calibration stability
    Firat Duru
    University Hospital, Rämistr 100 Zurich, CH 8091, Switzerland
    Pacing Clin Electrophysiol 25:1679-84. 2002
    ..These results have implications for patient monitoring applications using these sensors and for development of future pacemaker rate response algorithms...
  80. ncbi Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial
    Steven P Kutalek
    Drexel University College of Medicine, Philadelphia, Pennsylvania, USA
    Pacing Clin Electrophysiol 31:828-37. 2008
    ..Many patients had abnormalities for which pacing is often advocated to improve the management of ventricular dysfunction...
  81. ncbi Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up
    Antonio Rossillo
    Department of Cardiology, Umberto I Hospital, Mestre-Venice, Italy
    J Cardiovasc Electrophysiol 15:1120-5. 2004
    ..This improvement does not appear to influence mortality...
  82. ncbi Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
    Richard C Klein
    Cardiology Division, University of Utah Health Sciences Center and VA Medical Center, 50 N Medical Drive, Salt Lake City, UT 84132, USA
    J Cardiovasc Electrophysiol 14:940-8. 2003
    ..Arrhythmia recurrence rates in these patients are high, but which patients will receive a therapy and the forms of arrhythmia recurrence (VT or VF) are poorly understood...
  83. ncbi Complications arising after implantation of DDD pacemakers: the MOST experience
    Kenneth A Ellenbogen
    Division of Cardiology, Medical College of Virginia, PO Box 980053, Richmond, VA 23298 0053, USA
    Am J Cardiol 92:740-1. 2003
    ..This information may serve as a benchmark when comparing complication rates for dual-chamber pacemaker implantation with those for biventricular pacemaker implantation...
  84. ncbi Evaluation of ventricular synchrony using novel Doppler echocardiographic indices in patients with heart failure receiving cardiac resynchronization therapy
    Jing Ping Sun
    Cleveland Clinic Foundation and Medtronic, Inc, Minneapolis, MN, USA
    J Am Soc Echocardiogr 17:845-50. 2004
    ..LV and BiV pacing provides benefits that can be quantified by echocardiography...
  85. ncbi Safe scanning, but frequent artifacts mimicking bradycardia and tachycardia during magnetic resonance imaging (MRI) in patients with an implantable loop recorder (ILR)
    J Rod Gimbel
    Parkwest Hospital, 9330 Parkwest Boulevard, Ste 202, Knoxville, TN 37923, USA
    Ann Noninvasive Electrocardiol 10:404-8. 2005
    ..Little has been reported regarding the safety and effects of MRI scanning of patients with implantable loop recorders (ILRs). We evaluated the safety of scanning patients with ILRs and the output of the ILR after undergoing MRI...
  86. ncbi Lead failures: dealing with even less perfect
    Bruce L Wilkoff
    Heart Rhythm 4:897-9. 2007
  87. ncbi Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial
    Stuart J Connolly
    Department of Medicine, McMaster University, Hamilton, Ontario
    JAMA 289:2224-9. 2003
    ..However, because these trials were not double blind, they may have been biased in their assessment of outcomes and had a placebo effect of surgery...
  88. ncbi Safe, sensible, sagacious: responsible scanning of pacemaker patients
    J Rod Gimbel
    Eur Heart J 26:1683-4. 2005
  89. ncbi Diagnosis of sleep-related breathing disorders by visual analysis of transthoracic impedance signals in pacemakers
    Christoph Scharf
    Cardiovascular Center, University Hospital Zurich, Department of Internal Medicine, Division of Cardiology and Pneumology, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 110:2562-7. 2004
    ..We investigated whether this technique might detect sleep-related breathing disorders...
  90. ncbi Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients
    J Rod Gimbel
    Park West Hospital, Knoxville, Tennessee, USA
    Pacing Clin Electrophysiol 28:1041-6. 2005
    ..To determine if strategies used to safely scan nonpacemaker-dependent patients could be applied to facilitate safe MRI of pacemaker-dependent patients...
  91. ncbi Dynamic obstruction to coronary sinus access: the Thebesian valve
    Alexander J Hill
    Medtronic, Inc, Minneapolis, Minnesota 55455, USA
    Heart Rhythm 3:1240-1. 2006
  92. ncbi Group purchasing organizations: optimizing cardiac device selection, therapy delivery, and fiscal responsibility
    Mark W Sweesy
    Arrhythmia Technologies Institute, Greenville, South Carolina, USA
    Pacing Clin Electrophysiol 29:1404-9. 2006
    ..The guideline will only be effective when the physicians or cardiac device caregivers have the knowledge and skills to optimally program and match device therapies and algorithms to individual patient needs...
  93. ncbi Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs)
    J Rod Gimbel
    Park West Hospital, 9330 Park West Boulevard, Ste 202, Knoxville, TN 37923, USA
    Pacing Clin Electrophysiol 28:270-3. 2005
    ..To determine if simple strategies used to safely scan pacemaker patients could be applied to implantable cardioverter defibrillator (ICD), patients undergoing MRI allowing ICD patients to undergo MRI as well...